{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:55:50Z","timestamp":1792108550894,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.maturitas.2026.109023","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:04:54Z","timestamp":1781107494000},"page":"109023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Neurokinin pathway botanical antagonist for menopausal vasomotor symptoms: A randomized, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"211","author":[{"given":"Samuel","family":"Lederman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Minkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra Lisa","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jevaneeh","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Recker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois Xinjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"VanDusseldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2026.109023_bb0005","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/GME.0000000000002237","article-title":"Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey","volume":"30","author":"DePree","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0010","series-title":"\u201cThe 2022 Hormone Therapy Position Statement of The North American Menopause Society\u201d Advisory Panel, The 2022 hormone therapy position statement of The North American Menopause Society, Menopause","first-page":"767","volume":"29","year":"2022"},{"key":"10.1016\/j.maturitas.2026.109023_bb0015","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/GME.0000000000001237","article-title":"Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years","volume":"25","author":"Gartoulla","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.3128","article-title":"Menopausal hormone therapy use among postmenopausal women","volume":"5","author":"Yang","year":"2024","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.maturitas.2026.109023_bb0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/GME.0000000000001793","article-title":"Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden","volume":"28","author":"Nappi","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0030","series-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","article-title":"Fezolinetant","year":"2024"},{"key":"10.1016\/j.maturitas.2026.109023_bb0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s12325-024-03073-8","article-title":"Safety of Fezolinetant for treatment of moderate to severe vasomotor symptoms due to menopause: pooled analysis of three randomized phase 3 studies","volume":"42","author":"Kagan","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.maturitas.2026.109023_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12905-025-03774-4","article-title":"The effect of shared decision-making on the conflict and regret in menopause symptoms management: an interventional study","volume":"25","author":"Ghehi","year":"2025","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.maturitas.2026.109023_bb0045","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/S0140-6736(24)02602-3","article-title":"Menopause priority setting partnership steering group, top ten menopause research priorities","volume":"404","author":"Nash","year":"2025","journal-title":"Lancet"},{"issue":"Supplement 1","key":"10.1016\/j.maturitas.2026.109023_bb0050","doi-asserted-by":"crossref","first-page":"100580","DOI":"10.1016\/j.cdnut.2023.100580","article-title":"Therapeutic effects of a novel botanical blend on neurokinin B and kisspeptin in ovariectomized rats","volume":"7","author":"Sahin","year":"2023","journal-title":"Curr. Dev. Nutr."},{"issue":"2004","key":"10.1016\/j.maturitas.2026.109023_bb0055","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","author":"Maclennan","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2026.109023_bb0060","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/GME.0000000000000871","article-title":"Validity, cut-points, and minimally important differences for two hot flash-related daily interference scales","volume":"24","author":"Carpenter","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0065","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s12325-024-02787-z","article-title":"Psychometric evaluation of the MENQOL instrument in women experiencing vasomotor symptoms associated with menopause","volume":"41","author":"Schultz","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.maturitas.2026.109023_bb0070","series-title":"Menopausal Symptoms: Comparative Effectiveness of Therapies","author":"Grant","year":"2015"},{"key":"10.1016\/j.maturitas.2026.109023_bb0075","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/GME.0000000000000459","article-title":"Confirmatory factor analysis of the Pittsburgh Sleep Quality Index in women with hot flashes","volume":"22","author":"Otte","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/GME.0000000000002370","article-title":"Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core outcomes in menopause) consortium","volume":"31","author":"Lensen","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.2025.22259","article-title":"Updated labeling for menopausal hormone therapy","volume":"335","author":"Makary","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2026.109023_bb0090","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/14737167.2023.2250916","article-title":"Assessment of women\u2019s treatment preferences for vasomotor symptoms due to menopause","volume":"23","author":"Shiozawa","year":"2023","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.maturitas.2026.109023_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/gme.0b013e31813429d6","article-title":"Use of complementary and alternative medicine during the menopause transition: longitudinal results from the Study of Women\u2019s Health Across the Nation","volume":"15","author":"Bair","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0100","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/aje\/kwn410","article-title":"Trends in dietary supplement use in a cohort of postmenopausal women from Iowa","volume":"169","author":"Park","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.maturitas.2026.109023_bb0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neulet.2004.06.005","article-title":"Catechins prevents substance P-induced hyperactive bladder in rats via the downregulation of ICAM and ROS","volume":"367","author":"Chen","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.maturitas.2026.109023_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2007.06.004","article-title":"Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP","volume":"56","author":"Jin","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.maturitas.2026.109023_bb0115","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/jid.2011.96","article-title":"Curcumin mediates both dilation and constriction of peripheral arterioles via adrenergic receptors","volume":"131","author":"Dewar","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.maturitas.2026.109023_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ibneur.2023.11.008","article-title":"Curcumin mitigates the sleep-deprivation impacts on rat hypothalamic paraventricular nucleus","volume":"15","author":"Erfanizadeh","year":"2023","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.maturitas.2026.109023_bb0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.maturitas.2012.01.023","article-title":"Effective and clinically meaningful non-hormonal hot flash therapies","volume":"72","author":"Guttuso","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109023_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/GME.0000000000002281","article-title":"Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause","volume":"31","author":"Morga","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/GME.0000000000002328","article-title":"Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause","volume":"31","author":"Cieri-Hutcherson","year":"2024","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109023_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041258","article-title":"Evaluation of clinical meaningfulness of red clover (L.) extract to relieve hot flushes and menopausal symptoms in peri- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Kanadys","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.maturitas.2026.109023_bb0145","first-page":"169","article-title":"The effect of officinalis on hot flashes in postmenopausal women: a systematic review and meta-analysis","volume":"11","author":"Moradi","year":"2023","journal-title":"Int. J. Community Based Nurs. Midwifery"},{"key":"10.1016\/j.maturitas.2026.109023_bb0150","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.2016.8012","article-title":"Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis","volume":"315","author":"Franco","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2026.109023_bb0155","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamainternmed.2025.0990","article-title":"Nonhormonal treatment of menopausal vasomotor symptoms","volume":"185","author":"Huang","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.maturitas.2026.109023_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.108096","article-title":"Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: findings from the REALISE study","volume":"189","author":"Kingsberg","year":"2024","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109023_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/GCO.0000000000001012","article-title":"Sleep disturbance and menopause","volume":"37","author":"Carmona","year":"2025","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109023_bb0170","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1007\/s11325-024-03132-y","article-title":"Prevalence of poor sleep quality during menopause: a meta-analysis","volume":"28","author":"Jia","year":"2024","journal-title":"Sleep Breath."},{"key":"10.1016\/j.maturitas.2026.109023_bb0175","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(23)02802-7","article-title":"Managing menopause after cancer","volume":"403","author":"Hickey","year":"2024","journal-title":"Lancet"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226002008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:01:19Z","timestamp":1784761279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0378512226002008"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109023","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurokinin pathway botanical antagonist for menopausal vasomotor symptoms: A randomized, double-blind, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109023"}}